Listar por tema "risk management"

Ordenar por:Orden:Resultados:

  • Biological and nonbiological complex drugs for multiple sclerosis in Latin America: Regulations and risk management 
    Carrá, A.; Macías Islas, M.A.; Tarulla, A.; Bichuetti, D.B.; Finkelsztejn, A.; Dadalti Fragoso, Y.; Árcega-Revilla, R.; Cárcamo Rodríguez, C.; Durán, J.C.; García Bonitto, J.; León, Rosalba; Oehninger Gatti, C.; Orozco, G.; Vizcarra-Escobar, Darwin (Taylor and Francis, 2015)
    Biological drugs and nonbiological complex drugs with expired patents are followed by biosimilars and follow-on drugs that are supposedly similar and comparable with the reference product in terms of quality, safety and ...
  • Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America 
    Steinberg, Judith; Fragoso, Yara D.; Duran Quiroz, Juan Carlos; Garcia, Juan Raul; Guerra, Caroline; Rodriguez, Virginia; Carcamo Rodriguez, Claudia; Ciampi, Ethel; Correa-Diaz, Edgar; Macias, Miguel; Novarro, Nelson; Vizcarra-Escobar, Darwin; Oehninger Gatti, Carlos; Orozco, Geraldine; Carra, Adriana (Springer, 2019)
    The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the sustainability of healthcare systems, and improving patient ...
  • Seguridad del paciente y eventos adversos en la práctica odontológica en una clínica dental docente 
    Manrique-Guzmán, Jorge A.; Chávez-Reátegui, Beatriz del C.; Manrique-Chávez, Carolina B.; Manrique-Chávez, Jorge E. (Universidad Peruana Cayetano Heredia, 2022)
    Objective: To evaluate the frequency and distribution of adverse events that occur in the development of dental treatments performed by clinical operators of a Teaching Dental Clinic during 2015. Material and ...

Buscar en el Repositorio

Listar

Panel de Control